Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This trial is conducted in Europe. The aim of this clinical trial is to compare the blood glucose lowering effect of NN5401(insulin degludec/insulin aspart (IDegAsp)) with NN1250 (insulin degludec (IDeg)) and insulin aspart (IAsp) in subjects with type 1 diabetes where the trial participant will receive one single dose of each trial product in varying order.
Epistemonikos ID: 5211d8c78e1f9c30926dbc653986d242d3ca996a
First added on: May 05, 2024